By Eurand. Proprietary technologies enhance bioavailability of poorly soluble drug compounds.
The pharmaceutical industry has made dramatic contributions to improving both life expectancies and the quality of life around the world, yet it finds itself under tremendous pricing pressure for its products, says Alfred Sherk.
René Schwarz of Rockwell Automation tells NGP why manufacturing execution systems are important for achieving operational excellence.
A new report from A T Kearney’s highlights what the pharmaceutical industry must do to survive.
Travis Johnson of International Anti-Counterfeiting Coalition talks to NGP about the global problem of counterfeit pharmaceuticals.